Cargando…

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

Detalles Bibliográficos
Autor principal: Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254684/
https://www.ncbi.nlm.nih.gov/pubmed/30533190
http://dx.doi.org/10.18632/oncotarget.26296
_version_ 1783373780251312128
author Antonarakis, Emmanuel S.
author_facet Antonarakis, Emmanuel S.
author_sort Antonarakis, Emmanuel S.
collection PubMed
description
format Online
Article
Text
id pubmed-6254684
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62546842018-12-07 Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer Antonarakis, Emmanuel S. Oncotarget News Impact Journals LLC 2018-11-09 /pmc/articles/PMC6254684/ /pubmed/30533190 http://dx.doi.org/10.18632/oncotarget.26296 Text en Copyright: © 2018 Antonarakis http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Antonarakis, Emmanuel S.
Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title_full Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title_fullStr Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title_full_unstemmed Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title_short Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
title_sort selective inhibitors of nuclear export: potential therapeutics for ar variant-expressing prostate cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254684/
https://www.ncbi.nlm.nih.gov/pubmed/30533190
http://dx.doi.org/10.18632/oncotarget.26296
work_keys_str_mv AT antonarakisemmanuels selectiveinhibitorsofnuclearexportpotentialtherapeuticsforarvariantexpressingprostatecancer